SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCI...(7656 22397 23942 Genera...)

Date:11/5/2009

7,656 22,397 23,942 General and administrative (including $1,006, $942, $3,067 and $3,021, respectively, of non-cash stock-based compensation) 3,522 3,106 9,992 9,824 ------- ------- -------- -------- Total operating expenses 10,489 10,762 32,389 33,766 Loss from operations (6,332) (6,727) (21,754) (20,096) Other income 167 248 201 1,117 ------- ------- -------- -------- Net loss $(6,165) $(6,479) $(21,553) $(18,979) ======= ======= ======== ======== Basic and diluted net loss per share $(0.20) $(0.21) $(0.70) $(0.62) ======= ======= ======== ======== Weighted average shares used in computing basic and diluted net loss per share 30,968 30,617 30,883 30,580 ======= ======= ======== ======== Condensed Balance Sheets (in thousands) September 30, December 31, 2009 2008 ------------- ------------ (unaudited) Cash, cash equivalents and investments available-for-sale $33,007 $40,106 Other current assets 823 942 Property and equipment, net 11,289 13,418 ------- ------- Total assets $45,119 $54,466
'/>"/>

SOURCE Senomyx, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related biology technology :

1. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
6. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
7. SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
8. SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
9. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
10. SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE